Supreme Court blocks Trump limits on transgender federal prison healthcare

The Supreme Court has barred the Trump administration from implementing rules that would limit gender-affirming medical care and related accommodations for transgender individuals held in federal prisons.

In an unsigned order issued Wednesday, the high court turned down an emergency petition by the federal government attempting to lift a preliminary freeze imposed by a trial judge. Justices Clarence Thomas and Samuel Alito noted publicly that they would have granted the government's request to let the restrictions proceed, while the remainder of the bench did not offer written reasoning.

Under the disputed initiative, the Bureau of Prisons sought to discontinue transition-related surgeries, hormone regimens, and personal items such as cosmetics, padding, and wigs for approximately 1,000 transgender people in federal custody. The plan permitted only mental health services and psychiatric drugs such as antidepressants. Federal officials argued that medical consensus surrounding such care had grown uncertain, though major advocacy organizations strongly disputed that position.

The bureau's shift aligned with an executive order issued by President Donald Trump in January 2025 directing executive agencies to define sex strictly along binary biological lines and ignore broader notions of gender identity.

A legal challenge brought by several transgender inmates—including Alishea Kingdom, Jas Kapule, and Solo Nichols, all of whom have undergone hormone therapy over multiple years—prompted the court intervention. Represented by the American Civil Liberties Union, the plaintiffs argued that the sudden cutback violated the Eighth Amendment's protection against cruel and unusual punishment and breached administrative requirements by lacking sufficient justification.

U.S. District Judge Royce Lamberth initially blocked the rules, pointing out that prison officials had offered gender-affirming procedures for decades without providing internal medical data showing the prior setup had failed or caused harm. Lamberth determined that the stated medical concerns were merely a pretext designed to satisfy the White House directive. A divided panel on the U.S. Court of Appeals for the District of Columbia Circuit subsequently affirmed that injunction in September.

Government lawyers, led by Solicitor General D. John Sauer, contended that lower courts were improperly overriding executive policy determinations and penalizing the agency for carrying out the president's instructions. Attorneys for the ACLU countered that the bureau had safely administered hormone therapy since 1992 and could not legally discard long-standing practices without presenting sound medical rationale.

The outcome presents an uncommon victory for transgender rights before the current six-member conservative majority on the Supreme Court. In previous terms, the justices have permitted military restrictions on transgender service members, backed state limitations on youth gender transition therapies, and supported state measures excluding transgender athletes from female athletic categories.